First Light Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

First Light Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,200	Closed	-$969K	–	91
2020 Q4	$969K	Buy	+6,200	New	+$797K	0.07%	50
2020 Q2	–	Sell	-122,645	Closed	-$11M	–	73
2020 Q1	$11M	Buy	122,645 +96,361	+367%	+$9.46M	1.88%	21
2019 Q4	$2.84M	Sell	26,284 -414	-2%	-$44.3K	0.36%	41
2019 Q3	$2.62M	Sell	26,698 -222	-0.8%	-$25K	0.4%	44
2019 Q2	$3.53M	Buy	+26,920	New	+$3.47M	0.49%	42

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Light Asset Management's ALXN Position: Q1 2021 in Review

First Light Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 6,200 shares — an estimated $969K sold.

First Light Asset Management first reported a position in ALXN in Q2 2019 and held it in 5 quarters. The position peaked at $11M in Q1 2020. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

First Light Asset Management reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
First Light Asset Management sold 6,200 Alexion Pharmaceuticals shares in Q1 2021, an estimated $969K.
First Light Asset Management first reported a position in Alexion Pharmaceuticals in Q2 2019 and held it in 5 quarters.
First Light Asset Management's Alexion Pharmaceuticals position peaked at $11M in Q1 2020.
754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on First Light Asset Management's 13F filing for Q1 2021, filed 17 May 2021.